‌

US Patent 8609707 Formulations of bendamustine

Patent 8609707 was granted and assigned to Eagle Pharmaceuticals, Inc. on December, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Eagle Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86097070

Date of Patent

December 17, 2013

Patent Application Number

130164730

Date Filed

January 28, 2011

Patent Citations Received

‌

US Patent 11701344 Bendamustine pharmaceutical compositions

‌

US Patent 11707450 Stable pharmaceutical compositions of bendamustine

‌

US Patent 11872214 Formulations of Bendamustine

‌

US Patent 12059406 Stable pharmaceutical compositions of bendamustine

Patent Primary Examiner

‌

Blessing M Fubara

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8609707 Formulations of bendamustine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API